Oxcarbazepine Tablet, Film Coated
Product Images NDC 63629-6834

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Oxcarbazepine (NDC 63629-6834). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label Image (Lbl636296834)

Packaging label for Oxcarbazepine 600 mg tablet, film-coated, oral dosage form by Bryant Ranch Prepack. The label includes storage instructions, warning to keep out of reach of children, and indicates a 30-count package. It references comparison to Trileptal 600 mg tablet by Nexgen Pharma. The label also shows the NDC 63629-6834 and batch lot information.*

FDA Label Image

Chemical Structure (Oxcarbazepine 01)

Chemical structure of Oxcarbazepine showing a dibenzazepine derivative with a ketone group and an amide side chain attached to the nitrogen atom.*

FDA Label Image

Figure 1 (Oxcarbazepine 02)

A line graph depicting the exit rate over time on trial from Day 2 to Day 11. The graph compares two treatment groups: Oxcarbazepine and Placebo, with Oxcarbazepine represented by a solid line and Placebo by a dotted line. The y-axis shows exit rate from 0.0 to 1.0, while the x-axis shows time in days. A log-rank test p-value of 0.0001 is indicated on the graph.*

FDA Label Image

Figure 2 (Oxcarbazepine 03)

A Kaplan-Meier curve comparing seizure rates over days from first dose to first seizure between Oxcarbazepine treatment and placebo groups. The x-axis shows days up to 140, and the y-axis represents seizure rates from 0 to 1. The graph includes a log-rank test p-value of 0.046, indicating statistical analysis of the difference between groups.*

FDA Label Image

Figure 3 (Oxcarbazepine 04)

A Kaplan-Meier curve graph displaying exit rate over time in days, comparing two treatment groups labeled HIGH (solid line) and LOW (dotted line). The graph includes a log-rank test result with a p-value of 0.0001, indicating statistical comparison between the groups' exit rates over the study duration ranging up to 130 days.*

FDA Label Image

Figure 4 (Oxcarbazepine 05)

A Kaplan-Meier survival plot showing exit rates over time in days for two treatment groups labeled as HIGH and LOW. The x-axis represents time to exit in days up to 130 days, and the y-axis shows exit rate from 0 to 1. The LOW group has a higher exit rate over time than the HIGH group, with a log-rank test p-value of 0.0001 displayed on the plot.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.